- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06931587
Methanol Poisoning
Methyl Alcohol Intoxication as a Public Health Issue: A 3-Year Retrospective Analysis
This study addresses methyl alcohol intoxications with profound acidosis requiring intensive care treatment. The goal is to contribute both to the improvement of diagnosis and follow-up processes and to the development of management strategies under the highlight of existing literature.
This study is a single-center, retrospective, observational cohort study conducted on patients admitted to the ICU between January 2022 and March 2025 with suspected or laboratory-confirmed methyl alcohol intoxication. The investigators analyzed patients' demographic characteristics, prognostic clinical and laboratory parameters, treatment approaches and outcomes
Study Overview
Status
Conditions
Detailed Description
This study addresses methyl alcohol intoxications with profound acidosis requiring intensive care treatment. The objective is to contribute to the improvement of diagnostic and follow-up processes, as well as to the development of management strategies, in light of the existing literature.
The study is a single-center, retrospective, observational cohort analysis conducted on patients admitted to the intensive care unit (ICU) between January 2022 and March 2025 with suspected or laboratory-confirmed methyl alcohol intoxication.
Data collection was performed in three steps. Initially, the hospital's electronic medical database was searched using the ICD code T51.1 to identify relevant cases. Subsequently, detailed medical records were reviewed to assess clinical progress and treatment interventions. Finally, laboratory findings were obtained through the hospital's patient record system.
Demographic characteristics-including age and gender-reasons for ICU admission, pre-existing conditions, presenting symptoms, and disease severity based on Acute Physiology and Chronic Health Evaluation II (APACHE II), Glasgow Coma Scale (GCS), Sequential Organ Failure Assessment (SOFA), and Simplified Acute Physiology Score (SAPS) evaluated during the first 24 hours of ICU stay were retrospectively analyzed. Treatment interventions, including ethanol or fomepizole administration, the need for hemodialysis (intermittent hemodialysis [IHD] or continuous venovenous hemodialysis [CVVHD]), supportive therapies, ICU length of stay, and clinical outcomes were also documented.
Laboratory evaluations included arterial blood gas analysis, anion gap, osmolality, complete blood count, glucose, urea, creatinine, electrolytes (sodium, potassium, chloride), C-reactive protein (CRP), and organ function tests such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
Demographic data, prognostic clinical and laboratory parameters, treatment modalities, and clinical outcomes were analyzed by the investigators.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Istanbul
-
Kartal, Istanbul, Turkey, 34870
- Kartal Dr. Lütfi Kırdar City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
• Clinical diagnosis of methyl alcohol intoxication.
Exclusion Criteria:
- Other toxic alcohol intoxications
- Pregnant women
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ICU Mortality Among Patients With Methyl Alcohol Intoxication
Time Frame: Up to 30 days (during ICU follow-up)
|
Mortality was defined as death occurring during ICU stay among patients admitted with laboratory-confirmed or suspected methyl alcohol intoxication.
|
Up to 30 days (during ICU follow-up)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: banu çevik, professor doctor, Kartal Dr. Lütfi Kirdar City Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kartal City Hospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Methanol Poisoning
-
TakedaCompletedEthylene Glycol Poisoning, Methanol PoisoningJapan
-
Adana Numune Training and Research HospitalCompletedMethanol PoisoningTurkey
-
Oslo University HospitalLoghman-Hakim Hospital, Teheran, Iran; Shohada-e-Tajrish Hospital, Teheran,... and other collaboratorsWithdrawn
-
Ankara Universitesi TeknokentInternational Olympic CommitteeCompletedMagnetic Field Exposure | Methanol Poisoning | Toxic Optic Neuropathy | Stem Cell Tyrosine Kinase 1 Y842XTurkey
-
National Institute of Environmental Health Sciences...Health Canada; Danish Institute for Public Health; Indian and Northern Affairs...Completed
-
National Institute of Environmental Health Sciences...Completed
-
Sir Salimullah Medical College Mitford HospitalCompletedOrganophosphorus PoisoningBangladesh
-
Intermountain Health Care, Inc.Recruiting
-
University of EdinburghToxicology Society of BangladeshCompletedPesticide Poisoning | Anticholinesterase Insecticide PoisoningBangladesh
-
Intermountain Health Care, Inc.Enrolling by invitation